TORONTO, ONTARIO--(CCNMatthews - Oct. 26, 2006) - Orbus Pharma Inc. (TSX:ORB) (“Orbus”) today announced that patent applications for its instant release formulation of the drug fluvastatin has been published by the United States Patent and Trade-mark Office and the World Intellectual Property Office, the latter of which represents the potential for formalized patent applications in over 125 countries worldwide.
